TP53 Mutations are Important Predictor of Prognosis in Allo-HCT for MDS

TP53 Mutations are Important Predictor of Prognosis in Allo-HCT for MDS

User Photo
ASHReport

4 years
999 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Navneet Majhail, MD of Cleveland Clinic, discusses how TP53 mutations lead to poor overall survival in patients with MDS at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay
>